Votes: NJ A4052 | 2022-2023 | Regular Session

Bill Title: Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.

Spectrum: Strong Partisan Bill (Democrat 24-2)

Status: (Passed) 2024-01-08 - Approved P.L.2023, c.242. [A4052 Detail]

Text: Latest bill text (Amended) [HTML]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
SenateSenate Floor: Third Reading - Final Passage2023-12-213505040PassedLinkView
SenateSenate Floor: Substitute for S2710 (Voice Vote)2023-12-2100000PassedLinkView
SenateSenate Budget and Appropriations Committee: Reported Favorably2023-11-30904013PassedLinkView
AssemblyAssembly Floor: Third Reading - Final Passage2023-06-307505080PassedLinkView
AssemblyAssembly Appropriations Committee: Reported Favorably2023-06-221100011PassedLinkView
AssemblyAssembly Health Committee: Reported with Amendments2023-06-05903012PassedLinkView


Social Comments on NJ A4052

feedback